Respivert Ltd. (United Kingdom)

Homepage: respivert.com

Alternate names: RespiVert, Respivert Ltd.

ROR: 05tmv0f07

OpenAlex ID: I4405268105

RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation

2017 · Catherine E. Charron, Paul Russell, et al. · European Respiratory Journal · 54

Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma

2015 · Neil C. Thomson, Catherine E. Charron, et al. · Pulmonary Pharmacology & Therapeutics · 39

Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma

2016 · Stuart T. Onions, Kazuhiro Ito, et al. · Journal of Medicinal Chemistry · 19

88 Levofloxacin pharmacokinetics (PK) after administration of MP-376 (Levofloxacin inhalation solution; Aeroquin) in children with cystic fibrosis (CF)

2011 · G.L. Kearns, C.M. Rubino, et al. · Journal of Cystic Fibrosis · 19

Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease

2017 · Jürgen Knobloch, David Jungck, et al. · Journal of Allergy and Clinical Immunology · 8

RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus

2013 · Lindsey Cass, Kazuhiro Ito, et al. · European Respiratory Journal · 4

Safety, pharmacokinetic and pharmacodynamic profile of RV568, a narrow spectrum kinase inhibitor, following repeat inhaled dosing in COPD patients

2013 · Paul Russell, Lindsey Cass, et al. · European Respiratory Journal · 4

PUR1800 (RV1162), A novel narrow spectrum kinase inhibitor, but not Fluticasone, reduces TNFa-induced cytokine release by primary bronchial epithelial cells from healthy volunteers and COPD patients

2018 · Aidan Curran, Catherine Charron, et al. · European Respiratory Journal · 1

Novel narrow spectrum kinase inhibitors inhibit rhinovirus replication via enhancement of interferon expression in nasal epithelial cells of atopic and non-atopic patients

2011 · Marco Contoli, Kazuhiro Ito, et al. · European Respiratory Journal · 1

Comparison of respiratory virus infection between human nasal epithelial cell monolayer and air-liquid interface 3D culture

2011 · Kazuhiro Ito, Song Huang, et al. · European Respiratory Journal · 1

60 Effects of RV568, a novel narrow spectrum kinase inhibitor, on pro-inflammatory cytokine production in epithelial cells isolated from patients with cystic fibrosis

2011 · M. Coates, C. Charron, et al. · Journal of Cystic Fibrosis · 1

LATE-BREAKING ABSTRACT: Safety, pharmacokinetic and pharmacodynamic profile of RV1162, a narrow spectrum kinase inhibitor, in healthy subjects and COPD patients

2015 · Paul Russell, Chris Stevenson, et al. · European Respiratory Journal

Atorvastatin lowers inflammatory sputum mediators in smokers with asthma

2015 · Catherine Charron, Rekha Chaudhuri, et al. · European Respiratory Journal

Formoterol revertiert die Steroid-Resistenz von Interleukin-8 in humanen glatten Bronchialmuskelzellen bei COPD

2012 · J Knobloch, J Reichert, et al. · Pneumologie

Die Steroid-Resistenz von Interleukin-8 in humanen glatten Bronchialmuskelzellen bei COPD wird durch Formoterol revertiert

2011 · J Knobloch, J Reichert, et al. · Pneumologie

59 Effects of RV1088, a novel narrow spectrum kinase inhibitor, on pro-inflammatory cytokine production in epithelial cells isolated from patients with cystic fibrosis

2011 · M. Coates, C. Charron, et al. · Journal of Cystic Fibrosis

91 Medical rationale for nebulisation of a novel high-concentration (100mg/mL) aqueous azithromycin inhalation solution

2011 · M. Keller, J.M. Schierholz, et al. · Journal of Cystic Fibrosis

Works count: 17

Citation count: 419